104 related articles for article (PubMed ID: 24345889)
41. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
Zhang Z; Bu X; Chen H; Wang Q; Sha W
Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
[TBL] [Abstract][Full Text] [Related]
42. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Kaufhold S; Garbán H; Bonavida B
J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
[TBL] [Abstract][Full Text] [Related]
43. Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480.
Butler SJ; Richardson L; Farias N; Morrison J; Coomber BL
Biochem Biophys Res Commun; 2017 Aug; 490(1):29-35. PubMed ID: 28576498
[TBL] [Abstract][Full Text] [Related]
44. How to Assess Drug Resistance in Cancer Stem Cells.
De Angelis ML; De Maria R; Baiocchi M
Methods Mol Biol; 2018; 1692():107-115. PubMed ID: 28986891
[TBL] [Abstract][Full Text] [Related]
45. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D; Barraco N; Listì A; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
[TBL] [Abstract][Full Text] [Related]
46. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
Yu D; Liu Y; Yang J; Jin C; Zhao X; Cheng J; Liu X; Qi X
Cell Biochem Biophys; 2015 Jan; 71(1):261-9. PubMed ID: 25241082
[TBL] [Abstract][Full Text] [Related]
47. PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.
Almozyan S; Colak D; Mansour F; Alaiya A; Al-Harazi O; Qattan A; Al-Mohanna F; Al-Alwan M; Ghebeh H
Int J Cancer; 2017 Oct; 141(7):1402-1412. PubMed ID: 28614911
[TBL] [Abstract][Full Text] [Related]
48. Colorectal cancer defeating? Challenge accepted!
Di Franco S; Todaro M; Dieli F; Stassi G
Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
[TBL] [Abstract][Full Text] [Related]
49. [Research progression in colorectal cancer stem cells].
Wu TY; Cui L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):297-300. PubMed ID: 23536355
[TBL] [Abstract][Full Text] [Related]
50. Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes.
Jia Y; Chen J; Zhu H; Jia ZH; Cui MH
Oncol Rep; 2015 Nov; 34(5):2296-304. PubMed ID: 26324021
[TBL] [Abstract][Full Text] [Related]
51. Up-regulated NRIP2 in colorectal cancer initiating cells modulates the Wnt pathway by targeting RORβ.
Wen Z; Pan T; Yang S; Liu J; Tao H; Zhao Y; Xu D; Shao W; Wu J; Liu X; Wang Y; Mao J; Zhu Y
Mol Cancer; 2017 Jan; 16(1):20. PubMed ID: 28137278
[TBL] [Abstract][Full Text] [Related]
52. Dissecting the perivascular stem-cell niche: can we take tumor recurrence down a NOTCH?
Banu MA; Shin BJ; Boockvar JA
Neurosurgery; 2012 Apr; 70(4):N18-9. PubMed ID: 22426056
[No Abstract] [Full Text] [Related]
53. Comprehensive analysis of miRNAs expression profiles revealed potential key miRNA/mRNAs regulating colorectal cancer stem cell self-renewal.
Xu P; Wang J; Sun B; Xiao Z
Gene; 2018 May; 656():30-39. PubMed ID: 29496555
[TBL] [Abstract][Full Text] [Related]
54. [Mechanism of polycomb Bmi1-targeted therapy for colorectal cancer].
Zhang H; Ye YJ; Cui ZR; Wang S
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):623-6. PubMed ID: 21866458
[TBL] [Abstract][Full Text] [Related]
55. Circulating CD133: a promising biomarker, but what are we measuring?
D'Angelica MI
Ann Surg Oncol; 2012 Feb; 19(2):351-2. PubMed ID: 22094495
[No Abstract] [Full Text] [Related]
56. Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study.
Wang MC; Jiao M; Wu T; Jing L; Cui J; Guo H; Tian T; Ruan ZP; Wei YC; Jiang LL; Sun HF; Huang LX; Nan KJ; Li CL
Oncotarget; 2016 Feb; 7(8):9586-99. PubMed ID: 26840020
[TBL] [Abstract][Full Text] [Related]
57. Colorectal cancer stem cells and their implications for novel anticancer therapy.
Klotz D
Expert Rev Anticancer Ther; 2013 Apr; 13(4):461-8. PubMed ID: 23560840
[TBL] [Abstract][Full Text] [Related]
58. Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer.
Fesler A; Guo S; Liu H; Wu N; Ju J
Epigenomics; 2017 Jun; 9(6):793-796. PubMed ID: 28517961
[TBL] [Abstract][Full Text] [Related]
59. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients.
Xiang D; Cheng Z; Liu H; Wang X; Han T; Sun W; Li X; Yang W; Chen C; Xia M; Liu N; Yin S; Jin G; Lee T; Dong L; Hu H; Wang H; Ding J
Hepatology; 2017 May; 65(5):1566-1580. PubMed ID: 28059452
[TBL] [Abstract][Full Text] [Related]
60. Regulation of hematopoietic stem cells using protein transduction domain-fused Polycomb.
Kajiume T; Sera Y; Kawahara Y; Matsumoto M; Fukazawa T; Imura T; Yuge L; Kobayashi M
Exp Hematol; 2012 Sep; 40(9):751-760.e1. PubMed ID: 22634509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
